Product
Modern Packaging
All our is provided with modern and durable packaging.
New Technologies
We use new and innovative technologies in our work.
No data
No data
No data
No data
A few words
About us
Lorem ipsum dolor sit amet consectetuer adipiscing elit. Praesent vestibulum molestie lacus. Aenean nonummy hendrerit mauris. Phasellus porta. Fusce suscipit varius mi. Cum sociis...
856 +
Service Case
745 +
Excellent team
350 +
Cover industry
289 +
Honors
News
-
AACR Annual Meeting 2023 opens today, Sy...
SynRx Therapeutics attended the meeting and presented the latest preclinical data from the two projects in the form of posters .
View Details -
SY002
SY002 focuses on an undisclosed target X, a critical enzyme in DNA damage repair. The expression of X is scarce in normal cells, while is overexpressed in tumor cells. X shows synthetic lethality with BRCA1/2 mutations or homologous recombination defects.
View Details -
SY001
Genomic instability is a hallmark of cancer cells, which is largely caused by DNA damage repair defects. Targeting DNA damage repair pathways increases additional burdens to cancer cells and induces cancer cell lethality. This precision targeting strategy is called synthetic lethality.
View Details
Please contact us
—
We have created new technology under big data.The dangling aconite sat Accumsan pharetra. Haricot bean nec turpis neque.Sed Tortor Lacus, in eleifend vitae eros, fermenting bacteria leo.
Leave a Message
—
Contact
—
Building 1801, Building XX, Road XX, Guangdong
123-123-145658
000-123-145689
cbd@1562.163@gd.com
点击右上角
分享给朋友吧
